CD33 and cancer: Interestingly, addition of CD33+ MDSCs in both Jurkat and Raji cell culture accelerated the generation of drug-resistance, as evidenced by significant upregulation of P-gp, MRP expression just only after 3 cycles of Dox-treatment and designated as early passage (EP) cancer cells.